Anti-Omp34 antibodies protect against Acinetobacter baumannii in a murine sepsis model. (December 2021)
- Record Type:
- Journal Article
- Title:
- Anti-Omp34 antibodies protect against Acinetobacter baumannii in a murine sepsis model. (December 2021)
- Main Title:
- Anti-Omp34 antibodies protect against Acinetobacter baumannii in a murine sepsis model
- Authors:
- Naghipour Erami, Aleme
Rasooli, Iraj
Jahangiri, Abolfazl
Darvish Alipour Astaneh, Shakiba - Abstract:
- Abstract: Acinetobacter baumannii, an opportunistic extracellular pathogen is one of the major causes of nosocomial infections. Omp34, also known as Omp33-36, is a bacterial porin protein involved in the virulence and fitness of this pathogen by adhesion to the host cell. This antigen nominated as an appropriate candidate for immunization against A. baumannii . In this study, the expression of the recombinant Omp34 (rOmp34) was carried out in E. coli BL21 (DE3). The immunogenicity of the rOmp34 in A. baumannii was studied in a murine sepsis model. Antibody response in mice injected with the recombinant protein was assessed using indirect ELISA. Bactericidal activity of rOmp34-immunized mice sera (1:10 dilution) against A. baumannii ATCC 19606 after 0, 1, 2, 4, and 8 h of incubation at 37 °C was assessed. In addition to survival rate, load of bacteria in liver and spleen of the infected mice were evaluated. A high titer of specific antibody equivalent to optical density of 1.54 ± 0.06 against rOmp34 was elicited in the immunized mice sera. Viability of the A. baumannii incubated 8 h with immunized mice sera was 64%. Homogenized liver and spleen samples of the control mice challenged with A. baumannii were loaded with 8 × 10 3 and 9 × 10 3 CFU per gram tissue respectively 48 h post-challenge as against complete clearance of A. baumannii in the immunized group. The protective immunity was achieved by challenging the mice groups with 5 × LD50 of live A. baumannii . Omp34 can beAbstract: Acinetobacter baumannii, an opportunistic extracellular pathogen is one of the major causes of nosocomial infections. Omp34, also known as Omp33-36, is a bacterial porin protein involved in the virulence and fitness of this pathogen by adhesion to the host cell. This antigen nominated as an appropriate candidate for immunization against A. baumannii . In this study, the expression of the recombinant Omp34 (rOmp34) was carried out in E. coli BL21 (DE3). The immunogenicity of the rOmp34 in A. baumannii was studied in a murine sepsis model. Antibody response in mice injected with the recombinant protein was assessed using indirect ELISA. Bactericidal activity of rOmp34-immunized mice sera (1:10 dilution) against A. baumannii ATCC 19606 after 0, 1, 2, 4, and 8 h of incubation at 37 °C was assessed. In addition to survival rate, load of bacteria in liver and spleen of the infected mice were evaluated. A high titer of specific antibody equivalent to optical density of 1.54 ± 0.06 against rOmp34 was elicited in the immunized mice sera. Viability of the A. baumannii incubated 8 h with immunized mice sera was 64%. Homogenized liver and spleen samples of the control mice challenged with A. baumannii were loaded with 8 × 10 3 and 9 × 10 3 CFU per gram tissue respectively 48 h post-challenge as against complete clearance of A. baumannii in the immunized group. The protective immunity was achieved by challenging the mice groups with 5 × LD50 of live A. baumannii . Omp34 can be nominated as an immunogen that can bring about protection against Acinetobacter baumannii . Highlights: Omp34 is a porin protein involved in the virulence and fitness of A. baumannii . Recombinant Omp34 (rOmp34) was expressed and studied as immunogen in a murine model. rOmp34-immunized mice sera exhibited bactericidal effect against A. baumannii . A. baumannii was completely cleared from liver and spleen in the immunized group. rOmp34 is nominated as a potent candidate for immunization against A. baumannii . … (more)
- Is Part Of:
- Microbial pathogenesis. Volume 161:Part B(2021)
- Journal:
- Microbial pathogenesis
- Issue:
- Volume 161:Part B(2021)
- Issue Display:
- Volume 161, Issue 2 (2021)
- Year:
- 2021
- Volume:
- 161
- Issue:
- 2
- Issue Sort Value:
- 2021-0161-0002-0000
- Page Start:
- Page End:
- Publication Date:
- 2021-12
- Subjects:
- Acinetobacter baumannii. -- Immunogenicity. -- Omp34. -- Omp 33–36. -- Vaccine
Pathogenic microorganisms -- Periodicals
Pathology, Molecular -- Periodicals
Communicable Diseases -- microbiology -- Periodicals
Communicable Diseases -- parasitology -- Periodicals
Micro-organismes pathogènes -- Périodiques
Pathologie moléculaire -- Périodiques
Electronic journals
616.9041 - Journal URLs:
- http://www.sciencedirect.com/science/journal/08824010 ↗
http://firstsearch.oclc.org ↗
http://firstsearch.oclc.org/journal=0882-4010;screen=info;ECOIP ↗
http://www.elsevier.com/journals ↗ - DOI:
- 10.1016/j.micpath.2021.105291 ↗
- Languages:
- English
- ISSNs:
- 0882-4010
- Deposit Type:
- Legaldeposit
- View Content:
- Available online (eLD content is only available in our Reading Rooms) ↗
- Physical Locations:
- British Library DSC - 5756.955000
British Library DSC - BLDSS-3PM
British Library HMNTS - ELD Digital store - Ingest File:
- 20139.xml